Dr. Humphrey on Mogamulizumab for Cutaneous T-Cell Lymphoma
1 Vues
administrator
08/09/23
Jeffrey Humphrey, MD, president, Kyowa Hakko Kirin Pharma, Inc., discusses the benefits of mogamulizumab for the treatment of cutaneous T-cell lymphoma.
Montre plus
Commentaires de Facebook
Aucun commentaire trouvé